Walleye Trading LLC Incyte Corp Call Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$57.33 - $68.61 $366,912 - $439,104	6,400 Added 156.1%	10,500 $694,000
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $670,458 - $835,125	-13,100 Reduced 76.16%	4,100 $248,000
Q1 2024 May 15, 2024	SELL	$56.55 - $66.59 $2.84 Million - $3.34 Million	-50,200 Reduced 74.48%	17,200 $979,000
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $1.38 Million - $1.7 Million	26,500 Added 64.79%	67,400 $4.23 Million
Q3 2023 Nov 14, 2023	SELL	$57.77 - $65.93 $132,871 - $151,639	-2,300 Reduced 5.32%	40,900 $2.36 Million
Q2 2023 Aug 14, 2023	BUY	$60.95 - $75.51 $2.29 Million - $2.83 Million	37,500 Added 657.89%	43,200 $2.69 Million
Q1 2023 May 15, 2023	SELL	$70.23 - $86.01 $1.22 Million - $1.5 Million	-17,400 Reduced 75.32%	5,700 $411,000
Q4 2022 Feb 14, 2023	BUY	$67.18 - $84.11 $1.19 Million - $1.49 Million	17,700 Added 327.78%	23,100 $1.86 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $26,472 - $33,144	400 Added 8.0%	5,400 $360,000
Q2 2022 Aug 08, 2022	BUY	$66.18 - $83.18 $324,282 - $407,582	4,900 Added 4900.0%	5,000 $380,000
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $178,254 - $215,216	-2,700 Reduced 96.43%	100 $8,000
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $75,537 - $92,422	-1,100 Reduced 28.21%	2,800 $193,000
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $327,467 - $358,873	-4,100 Reduced 51.25%	3,900 $328,000
Q1 2021 May 17, 2021	BUY	$76.02 - $100.5 $600,558 - $793,950	7,900 Added 7900.0%	8,000 $650,000
Q3 2020 Nov 16, 2020	SELL	$85.07 - $109.69 $85,070 - $109,690	-1,000 Reduced 90.91%	100 $9,000
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $1.05 Million - $1.54 Million	-14,100 Reduced 92.76%	1,100 $114,000
Q1 2020 May 15, 2020	BUY	$63.18 - $85.97 $157,950 - $214,925	2,500 Added 19.69%	15,200 $1.11 Million
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $1.03 Million - $1.35 Million	-14,100 Reduced 52.61%	12,700 $1.11 Million
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $342,253 - $406,644	-4,700 Reduced 14.92%	26,800 $1.99 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $529,344 - $638,640	7,200 Added 29.63%	31,500 $2.68 Million
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $1.44 Million - $2 Million	22,700 Added 1418.75%	24,300 $2.09 Million
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $292,500 - $349,700	-5,000 Reduced 75.76%	1,600 $102,000
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $265,525 - $319,189	4,300 Added 186.96%	6,600 $456,000
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $139,955 - $193,154	2,300 New	2,300 $154,000

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account